| AIDS Therapy Area Pipeline Report contains detailed | | | | Therapy Area Pipeline Report also provides detail on |
| information on the aids drug pipeline. This report | | | | the top 20 companies with products in the early |
| provides insight into the pipeline status of aids drugs | | | | stage of development and the top 20 companies |
| by company and by stage as well as a summary of | | | | with products in the late stage of development. |
| the latest news and developments in this area. | | | | Finally, each report also provides a comparison with |
| Scope of the report: | | | | other major indications in the disease hub based on |
| Each Life Science Analytics' Therapy Area Pipeline | | | | Marketed Products vs. Pipeline Products. |
| Report provides the user with real detail on drug | | | | Key benefits |
| pipelines, by company and by stage, for each specific | | | | • Understand a company's strategic position by |
| therapy area. The latest news, by company, also | | | | accessing detailed independent intelligence on its |
| ensures that each report is fresh and up-to-date. | | | | product pipeline for specific therapy areas. |
| In addition to new developments and disease specific | | | | • Keep track of your competitors and partners by |
| pipeline projects, each report also contains extensive | | | | better understanding their product pipeline. |
| information in tabular format on a company's full | | | | • Monitor a company's research effectiveness by |
| product pipeline and products by phase of | | | | determining pipeline depth and number of products in |
| development with regard to the therapy area. | | | | development by clinical phase for specific disease |
| Full pipeline details, by stage, are provided and include | | | | areas. |
| detailed product descriptions, information on | | | | • Maintain a critical competitive advantage. |
| partnering activity plus clinical trial intelligence. Each | | | | |